Verification evidence is still being completed.
PDF / print export
Orexo
Uppsala, Sweden
- Verified lead
- Nikolaj Sorensen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and CEO
- 2026 technical specialization
- Pharmaceutical Development, Drug Delivery, Formulation Technology, Addiction Medicine, and R&D Operations
- Review cycle
- May 2026
- Full address
- Orexo AB, Rapsgatan 7E, Uppsala, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Orexo contact page confirming the Uppsala visiting address.
- Editorial note
- Orexo is published because official company materials confirm current leadership, Uppsala headquarters address, and an active Swedish drug-development platform.
Pharmaceutical Development, Drug Delivery, Formulation Technology, Addiction Medicine, and R&D Operations
Official leadership disclosure, Official Uppsala address disclosure, R&D and headquarters platform claim
Orexo is published because official company materials confirm current leadership, Uppsala headquarters address, and an active Swedish drug-development platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Uppsala, Sweden
Orexo
Pharmaceutical Development, Drug Delivery, Formulation Technology, Addiction Medicine, and R&D Operations · R&D and development platform
Orexo runs drug product development, formulation platform development, and r&d operations in Uppsala, Sweden.
- Lead
- Nikolaj Sorensen (verified ↗)
- Address
- Orexo AB, Rapsgatan 7E, Uppsala, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- R&D and development platform
- Capabilities
- Drug Product Development · Formulation Platform Development · R&D Operations
- Founded
- 1995
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Nikolaj Sorensen
President and CEO
Full addressOrexo AB, Rapsgatan 7E, Uppsala, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
R&D and development platform
Uppsala, Sweden. Pharmaceutical Development, Drug Delivery, Formulation Technology, Addiction Medicine, and R&D Operations. Review completed on 21 Mar 2026.
Swedish corporate and pharmaceutical-development oversight
Official leadership disclosure, Official Uppsala address disclosure, R&D and headquarters platform claim
Pharmaceutical Development, Drug Delivery, Formulation Technology, Addiction Medicine, and R&D Operations
Orexo is published because official company materials confirm current leadership, Uppsala headquarters address, and an active Swedish drug-development platform.
Editorial note
Orexo is published because official company materials confirm current leadership, Uppsala headquarters address, and an active Swedish drug-development platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Drug Product Development
Formulation Platform Development
R&D Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Formulation-development workflow
R&D laboratory systems
Drug-development infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Orexo located?
- Orexo operates from Orexo AB, Rapsgatan 7E, Uppsala, Sweden, Uppsala, Sweden.
- Who runs Orexo?
- Orexo is led by Nikolaj Sorensen, President and CEO. Verified 21 Mar 2026.
- What does Orexo do?
- Orexo runs drug product development, formulation platform development, and r&d operations in Uppsala, Sweden. Core capabilities: Drug Product Development, Formulation Platform Development, R&D Operations.
Editorial context
Related technical briefs
Briefs that name Uppsala as a covered market or city.